guidebook. - Fanconi Anemia Research Fund

198
Fanconi Anemia: Guidelines for Diagnosis and Management
elsewhere. 1-9 From these institutional and registry studies,
four important findings emerge: 1) survival rates at
three years after alternate donor HSCT range between
40-75%; 2) regimen-related toxicity and infection are
the primary reasons for treatment failure; 3) risk factors
for best outcome after alternative donor HSCT are: age